Michelson Medical Research Foundation’s iShares Biotechnology ETF IBB Stock Holding History

Michelson Medical Research Foundation’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.67M	Hold	35,095	–	–	6.17%	8
2026 Q1	$5.93M	Hold	35,095	–	–	6.02%	6
2025 Q4	$5.92M	Hold	35,095	–	–	5.94%	7
2025 Q3	$5.07M	Hold	35,095	–	–	4.41%	9
2025 Q2	$4.44M	Sell	35,095 -8,300	-19%	-$1.02M	4.26%	10
2025 Q1	$5.55M	Hold	43,395	–	–	4.64%	9
2024 Q4	$5.74M	Hold	43,395	–	–	4.81%	8
2024 Q3	$6.32M	Hold	43,395	–	–	4.45%	9
2024 Q2	$5.96M	Hold	43,395	–	–	5.12%	7
2024 Q1	$5.95M	Hold	43,395	–	–	3.61%	10
2023 Q4	$5.9M	Hold	43,395	–	–	3.89%	11
2023 Q3	$5.31M	Hold	43,395	–	–	3.58%	10
2023 Q2	$5.51M	Hold	43,395	–	–	3.92%	11
2023 Q1	$5.6M	Hold	43,395	–	–	4.39%	10
2022 Q4	$5.7M	Buy	+43,395	New	+$5.61M	3.69%	9

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Michelson Medical Research Foundation's IBB Position: Q2 2026 in Review

Michelson Medical Research Foundation held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 35,095 shares worth $6.67M. The position accounts for 6.17% of the portfolio, ranked #8.

Michelson Medical Research Foundation first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Michelson Medical Research Foundation held 35,095 shares of iShares Biotechnology ETF worth $6.67M as of Q2 2026.
Michelson Medical Research Foundation left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 6.17% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #8 holding.
Michelson Medical Research Foundation first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.